sun pharma news: u.s. fda lists company's halol plant under an import alert | halftime report
Published 1 year ago • 2.9K plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
2:16
sun pharma's halol facility receives u.s. fda warning letter | business lunch | cnbc-tv18
-
2:36
u.s. fda issues warning letter to sun pharma, questions manufacturing practices at halol facility
-
0:47
#shorts | sun pharma shares tank after us fda issues 10 observations to its halol facility
-
5:10
vishal manchanda on impact of u.s fda oai status on sun pharma | bazaar open exchange | cnbc-tv18
-
3:06
sun pharma receives warning letter from us fda for its halol plant
-
7:29
the u.s. is enjoying a 'goldilocks' moment, says bofa's savita subramanian
-
2:25
markets looking at a 'record global energy crisis' if strait of hormuz is affected, says analyst
-
3:48
fed will have a series of 25 bps rate cuts going forward, says wharton's jeremy siegel
-
23:34
sun pharma in focus | us fda to re-inspect halol unit | movers & shakers | cnbc tv18
-
1:09
u.s fda woes for sun pharma, gets 6 observations for mohali plant | business lunch | cnbc-tv18
-
2:20
boost for sun pharma | u.s.fda nod for 1st product from halol | cnbc tv18
-
2:47
sun pharma halol plant | us fda issues 3 observations in form 483 | cnbc tv18
-
2:26
here are key expectations from sun pharma's q3fy23 earnings | halftime report | cnbc-tv18
-
23:49
us fda issues 6 observation on sun pharma | halftime report | cnbc-tv18
-
1:59
global pharma under u.s fda scanner, receives import alert | business lunch | cnbc-tv18
-
3:03
sun pharma dadra unit: us fda warning letter shows multiple repeat observations | n18v | cnbc tv18
-
2:38
relief for sun pharma: us fda clears sun pharma's dadra unit
-
11:40
sun pharma: us fda's bitter pill. catch all the details on markets today
-
2:26
market pulse- u.s.fda issues import alert on sun pharma
-
17:26
sun pharma rise over 2% post usfda nod for eye drug | halftime report | cnbc-tv18
-
1:23
us fda lifts ban on sun pharma's mohali plant
-
1:18
us fda records 11 observations for sun pharma’s dadra facility